The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
The renin-angiotensin system: going beyond the classical paradigms
Open accessAbstract
Thirty years ago, a novel axis of the renin-angiotensin system (RAS) was unveiled by the discovery of angiotensin-(1−7) [ANG-(1−7)] generation in vivo. Later, angiotensin-converting enzyme 2 (ACE2) was shown to be the main mediator of this reaction, and Mas was found to be the receptor for the heptapeptide. The functional analysis of this novel axis of the RAS that followed its discovery revealed numerous protective actions in particular for cardiovascular diseases. In parallel, similar protective actions were also described for one of the two receptors of ANG II, the ANG II type 2 receptor (AT 2 R), in contrast to the other, the ANG II type 1 receptor (AT 1 R), which mediates deleterious actions of this peptide, e.g., in the setting of cardiovascular disease. Very recently, another branch of the RAS was discovered, based on angiotensin peptides in which the amino-terminal aspartate was replaced by alanine, the alatensins. Ala-ANG-(1−7) or alamandine was shown to interact with Mas-related G protein-coupled receptor D, and the first functional data indicated that this peptide also exerts protective effects in the cardiovascular system. This review summarizes the presentations given at the International Union of Physiological Sciences Congress in Rio de Janeiro, Brazil, in 2017, during the symposium entitled “The Renin-Angiotensin System: Going Beyond the Classical Paradigms,” in which the signaling and physiological actions of ANG-(1−7), ACE2, AT 2 R, and alatensins were reported (with a focus on noncentral nervous system-related tissues) and the therapeutic opportunities based on these findings were discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 2×
“Diabetes and obesity are major causes of cardiovascular morbidity and mortality worldwide and result in microvascular and macrovascular complications, including hypertension (174).”
BackgroundHamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“ACE2 is widely expressed in the cardiovascular system, kidneys, lungs, and brain to protect these organs from excessive ANG II signaling (32, 42, 54, 71, 99, 161).”
BackgroundAkt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093 · cited 1×
“Obesity, the major metabolic precursor to type 2 diabetes, is an independent risk factor for the development of HF with preserved ejection fraction (HFpEF) (68, 69, 98, 166).”
BackgroundGrundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Self-citationHydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
FOXO transcription factors at the interface between longevity and tumor suppression
Greer, E. L., & Brunet, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209086 · Cited by 1,310
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Self-citationSignaling Pathways for Cardiac Hypertrophy and Failure
Hunter, J. J., & Chien, K. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411706 · Cited by 869
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Self-citationIdentification of angiotensin II receptor subtypes
Chiu, A. T., Herblin, W. F., McCall, D. E., Ardecky, R. J., Carini, D. J., Duncia, J. V., Pease, L. J., Wong, P. C., Wexler, R. R., Johnson, A. L., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91054-1 · Cited by 819
Tigerstedt, R., & Bergman, P. Q. (1898) · Skandinavisches Archiv Für Physiologie · doi:10.1111/j.1748-1716.1898.tb00272.x · Cited by 794
Preliminary biochemical characterization of two angiotensin II receptor subtypes
Whitebread, S., Mele, M., Kamber, B., & de Gasparo, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92133-5 · Cited by 777
A Diverse Family of GPCRs Expressed in Specific Subsets of Nociceptive Sensory Neurons
Dong, X., Han, S.-K., Zylka, M. J., Simon, M. I., & Anderson, D. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00483-4 · Cited by 737
Hypertension: Renin–Angiotensin–Aldosterone System Alterations
te Riet, L., van Esch, J. H. M., Roks, A. J. M., van den Meiracker, A. H., & Danser, A. H. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303587 · Cited by 706
Angiotensin II type 2 receptor mediates programmed cell death.
Yamada, T., Horiuchi, M., & Dzau, V. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.156 · Cited by 697
RICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M. (2004) · Biochemical Journal · doi:10.1042/bj20040634 · Cited by 619
Mitochondrial Energetics in the Heart in Obesity-Related Diabetes
Boudina, S., Sena, S., Theobald, H., Sheng, X., Wright, J. J., Hu, X. X., Aziz, S., Johnson, J. I., Bugger, H., Zaha, V. G., et al. (2007) · Diabetes · doi:10.2337/db07-0481 · Cited by 586
Sampaio, W. O., Souza dos Santos, R. A., Faria-Silva, R., da Mata Machado, L. T., Schiffrin, E. L., & Touyz, R. M. (2007) · Hypertension · doi:10.1161/01.hyp.0000251865.35728.2f · Cited by 562
From, A. M., Scott, C. G., & Chen, H. H. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.003 · Cited by 469
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 457
Self-citationDiscovery and Characterization of Alamandine: A Novel Component of the Renin–Angiotensin System
Lautner, R. Q., Villela, D. C., Fraga-Silva, R. A., Silva, N., Verano-Braga, T., Costa-Fraga, F., Jankowski, J., Jankowski, V., Sousa, F., Alzamora, A., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301077 · Cited by 438
Self-citationCongestive Heart Failure: Fifty Years of Progress
Braunwald, E., & Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_4.iv-14 · Cited by 437
Doobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L., & Lazartigues, E. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00292.2006 · Cited by 406
Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRs
Lembo, P. M. C., Grazzini, E., Groblewski, T., O'Donnell, D., Roy, M.-O., Zhang, J., Hoffert, C., Cao, J., Schmidt, R., Pelletier, M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn815 · Cited by 385
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M., et al. (2005) · Gut · doi:10.1136/gut.2004.062398 · Cited by 334
Patel, V. B., Clarke, N., Wang, Z., Fan, D., Parajuli, N., Basu, R., Putko, B., Kassiri, Z., Turner, A. J., & Oudit, G. Y. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.017 · Cited by 321
Self-citationAngiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
Loot, A. E., Roks, A. J. M., Henning, R. H., Tio, R. A., Suurmeijer, A. J. H., Boomsma, F., & van Gilst, W. H. (2002) · Circulation · doi:10.1161/01.cir.0000013847.07035.b9 · Cited by 321
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Tallant, E. A., Ferrario, C. M., & Gallagher, P. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2004 · Cited by 318
Wysocki, J., Ye, M., Rodriguez, E., González-Pacheco, F. R., Barrios, C., Evora, K., Schuster, M., Loibner, H., Brosnihan, K. B., Ferrario, C. M., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.138420 · Cited by 300
Metabolism of Angiotensin-(1–7) by Angiotensin-Converting Enzyme
Chappell, M. C., Pirro, N. T., Sykes, A., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.362 · Cited by 289
Schiavone, M. T., Santos, R. A., Brosnihan, K. B., Khosla, M. C., & Ferrario, C. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4095 · Cited by 288
Self-citationAngiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells
Sampaio, W. O., Henrique de Castro, C., Santos, R. A. S., Schiffrin, E. L., & Touyz, R. M. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.084848 · Cited by 283
Self-citationBiochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?
Chappell, M. C. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2015 · Cited by 280
Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M., & Scholey, J. W. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060977 · Cited by 273
Self-citationOcaranza, M. P., Godoy, I., Jalil, J. E., Varas, M., Collantes, P., Pinto, M., Roman, M., Ramirez, C., Copaja, M., Diaz-Araya, G., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000237862.94083.45 · Cited by 273
Kaschina, E., Grzesiak, A., Li, J., Foryst-Ludwig, A., Timm, M., Rompe, F., Sommerfeld, M., Kemnitz, U. R., Curato, C., Namsolleck, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.784868 · Cited by 261
Self-citationPatel, V. B., Mori, J., McLean, B. A., Basu, R., Das, S. K., Ramprasath, T., Parajuli, N., Penninger, J. M., Grant, M. B., Lopaschuk, G. D., et al. (2016) · Diabetes · doi:10.2337/db15-0399 · Cited by 255
Self-citationBottari, S. P., King, I. N., Reichlin, S., Dahlstroem, I., Lydon, N., & de Gasparo, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91629-5 · Cited by 252
Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
Epelman, S., Tang, W. H. W., Chen, S. Y., Van Lente, F., Francis, G. S., & Sen, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.088 · Cited by 250
Body Mass Index and Vigorous Physical Activity and the Risk of Heart Failure Among Men
Kenchaiah, S., Sesso, H. D., & Gaziano, J. M. (2009) · Circulation · doi:10.1161/circulationaha.108.807289 · Cited by 250
Deddish, P. A., Marcic, B., Jackman, H. L., Wang, H.-Z., Skidgel, R. A., & Erdös, E. G. (1998) · Hypertension · doi:10.1161/01.hyp.31.4.912 · Cited by 244
Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice
Santos, R. A. S., Castro, C. H., Gava, E., Pinheiro, S. V. B., Almeida, A. P., de Paula, R. D., Cruz, J. S., Ramos, A. S., Rosa, K. T., Irigoyen, M. C., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000215289.51180.5c · Cited by 237
Self-citationIwata, M., Cowling, R. T., Gurantz, D., Moore, C., Zhang, S., Yuan, J. X.-J., & Greenberg, B. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00317.2005 · Cited by 231
The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells
Meffert, S., Stoll, M., Steckelings, U. M., Bottari, S. P., & Unger, T. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03873-7 · Cited by 229
Self-citationBEDECS, K., ELBAZ, N., SUTREN, M., MASSON, M., SUSINI, C., STROSBERG, A. D., & NAHMIAS, C. (1997) · Biochemical Journal · doi:10.1042/bj3250449 · Cited by 226
Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
Mercure, C., Yogi, A., Callera, G. E., Aranha, A. B., Bader, M., Ferreira, A. J., Santos, R. A. S., Walther, T., Touyz, R. M., & Reudelhuber, T. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.184911 · Cited by 226
Self-citationKassiri, Z., Zhong, J., Guo, D., Basu, R., Wang, X., Liu, P. P., Scholey, J. W., Penninger, J. M., & Oudit, G. Y. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.840124 · Cited by 226
Self-citationStructural basis for selectivity and diversity in angiotensin II receptors
Zhang, H., Han, G. W., Batyuk, A., Ishchenko, A., White, K. L., Patel, N., Sadybekov, A., Zamlynny, B., Rudd, M. T., Hollenstein, K., et al. (2017) · Nature · doi:10.1038/nature22035 · Cited by 220
Patel, V. B., Shah, S., Verma, S., & Oudit, G. Y. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9644-1 · Cited by 218
Self-citationCirculating ACE2 activity is increased in patients with type 1 diabetes and vascular complications
Soro-Paavonen, A., Gordin, D., Forsblom, C., Rosengard-Barlund, M., Waden, J., Thorn, L., Sandholm, N., Thomas, M. C., & Groop, P.-H. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f04b6 · Cited by 208
Rice, A. S. C., Dworkin, R. H., McCarthy, T. D., Anand, P., Bountra, C., McCloud, P. I., Hill, J., Cutter, G., Kitson, G., Desem, N., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62337-5 · Cited by 204
Jorde, U. P., Ennezat, P. V., Lisker, J., Suryadevara, V., Infeld, J., Cukon, S., Hammer, A., Sonnenblick, E. H., & Le Jemtel, T. H. (2000) · Circulation · doi:10.1161/01.cir.101.8.844 · Cited by 202
Mass-Spectrometric Identification of a Novel Angiotensin Peptide in Human Plasma
Jankowski, V., Vanholder, R., van der Giet, M., Tölle, M., Karadogan, S., Gobom, J., Furkert, J., Oksche, A., Krause, E., Anh Tran, T. N., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000253889.09765.5f · Cited by 197
Self-citationSelective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling
Langlet, F., Haeusler, R. A., Lindén, D., Ericson, E., Norris, T., Johansson, A., Cook, J. R., Aizawa, K., Wang, L., Buettner, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.045 · Cited by 197
Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
Basu, R., Poglitsch, M., Yogasundaram, H., Thomas, J., Rowe, B. H., & Oudit, G. Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.064 · Cited by 196
Self-citationMori, J., Patel, V. B., Abo Alrob, O., Basu, R., Altamimi, T., DesAulniers, J., Wagg, C. S., Kassiri, Z., Lopaschuk, G. D., & Oudit, G. Y. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000672 · Cited by 192
Self-citationEndothelial Dysfunction and Elevated Blood Pressure in Mas Gene-Deleted Mice
Xu, P., Costa-Goncalves, A. C., Todiras, M., Rabelo, L. A., Sampaio, W. O., Moura, M. M., Sousa Santos, S., Luft, F. C., Bader, M., Gross, V., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.102764 · Cited by 191
Self-citationOrgan-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents
Gembardt, F., Sterner-Kock, A., Imboden, H., Spalteholz, M., Reibitz, F., Schultheiss, H.-P., Siems, W.-E., & Walther, T. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.009 · Cited by 190
Wang, W., McKinnie, S. M. K., Farhan, M., Paul, M., McDonald, T., McLean, B., Llorens-Cortes, C., Hazra, S., Murray, A. G., Vederas, J. C., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06892 · Cited by 190
Self-citationGuy, J. L., Jackson, R. M., Acharya, K. R., Sturrock, E. D., Hooper, N. M., & Turner, A. J. (2003) · Biochemistry · doi:10.1021/bi035268s · Cited by 189
Nouet, S., Amzallag, N., Li, J.-M., Louis, S., Seitz, I., Cui, T.-X., Alleaume, A.-M., Di Benedetto, M., Boden, C., Masson, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403880200 · Cited by 189
Converting enzyme activity and angiotensin metabolism in the dog brainstem.
Santos, R. A., Brosnihan, K. B., Chappell, M. C., Pesquero, J., Chernicky, C. L., Greene, L. J., & Ferrario, C. M. (1988) · Hypertension · doi:10.1161/01.hyp.11.2_pt_2.i153 · Cited by 186
Self-citationKang, J., Posner, P., & Sumners, C. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.5.c1389 · Cited by 173
Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats
Campagnole-Santos, M. J., Diz, D. I., Santos, R. A., Khosla, M. C., Brosnihan, K. B., & Ferrario, C. M. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.1.h324 · Cited by 171
Self-citationXu, J., Sriramula, S., Xia, H., Moreno-Walton, L., Culicchia, F., Domenig, O., Poglitsch, M., & Lazartigues, E. (2017) · Circulation Research · doi:10.1161/circresaha.116.310509 · Cited by 171
Ramchand, J., Patel, S. K., Srivastava, P. M., Farouque, O., & Burrell, L. M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198144 · Cited by 166
Kassiri, Z., Oudit, G. Y., Sanchez, O., Dawood, F., Mohammed, F. F., Nuttall, R. K., Edwards, D. R., Liu, P. P., Backx, P. H., & Khokha, R. (2005) · Circulation Research · doi:10.1161/01.res.0000178789.16929.cf · Cited by 165
Self-citationMolecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
Dias-Peixoto, M. F., Santos, R. A. S., Gomes, E. R. M., Alves, M. N. M., Almeida, P. W. M., Greco, L., Rosa, M., Fauler, B., Bader, M., Alenina, N., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114280 · Cited by 163
Self-citationACE2, angiotensin-(1–7), and Mas: the other side of the coin
Bader, M. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1120-0 · Cited by 158
Self-citationImmunologic Effects of the Renin-Angiotensin System
Crowley, S. D., & Rudemiller, N. P. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101066 · Cited by 156
AT 2 Receptor-Mediated Relaxation Is Preserved After Long-Term AT 1 Receptor Blockade
Widdop, R. E., Matrougui, K., Levy, B. I., & Henrion, D. (2002) · Hypertension · doi:10.1161/01.hyp.0000033224.99806.8a · Cited by 153
Fontes, M. A. P., Silva, L. C. S., Campagnole‐Santos, M. J., Khosla, M. C., Guertzenstein, P. G., & Santos, R. A. S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91171-1 · Cited by 150
Self-citationLessons from SARS: control of acute lung failure by the SARS receptor ACE2
Kuba, K., Imai, Y., Rao, S., Jiang, C., & Penninger, J. M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0094-9 · Cited by 149
Marques, F. D., Ferreira, A. J., Sinisterra, R. D., Jacoby, B. A., Sousa, F. B. D., Caliari, M. V., Silva, G. A. B., Melo, M. B., Nadu, A. P., de Souza, L. E., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.167346 · Cited by 148
Self-citationShaltout, H. A., Westwood, B. M., Averill, D. B., Ferrario, C. M., Figueroa, J. P., Diz, D. I., Rose, J. C., & Chappell, M. C. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00139.2006 · Cited by 147
Tetzner, A., Gebolys, K., Meinert, C., Klein, S., Uhlich, A., Trebicka, J., Villacañas, Ó., & Walther, T. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07572 · Cited by 146
Wei, C., Hase, N., Inoue, Y., Bradley, E. W., Yahiro, E., Li, M., Naqvi, N., Powell, P. C., Shi, K., Takahashi, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39345 · Cited by 142
Genetically altered animal models for Mas and angiotensin‐(1–7)
Alenina, N. V., Xu, P., Rentzsch, B., Patkin, E. L., & Bäder, M. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2007.040345 · Cited by 142
Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteins
Bottari, S. P., Taylor, V., King, I. N., Bogdal, Y., Whitebread, S., & de Gasparo, M. (1991) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(91)90091-u · Cited by 137
Kang, J., Richards, E. M., Posner, P., & Sumners, C. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.1.c278 · Cited by 133
Petrie, M. C., Padmanabhan, N., McDonald, J. E., Hillier, C., Connell, J., & McMurray, J. J. V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01111-1 · Cited by 129
Guy, J. L., Jackson, R. M., Jensen, H. A., Hooper, N. M., & Turner, A. J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04756.x · Cited by 129
AT2 Receptor and Tissue Injury: Therapeutic Implications
Namsolleck, P., Recarti, C., Foulquier, S., Steckelings, U. M., & Unger, T. (2014) · Current Hypertension Reports · doi:10.1007/s11906-013-0416-6 · Cited by 126
Self-citationGwathmey, T. M., Pendergrass, K. D., Reid, S. D., Rose, J. C., Diz, D. I., & Chappell, M. C. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.141622 · Cited by 126
Pathways for angiotensin-(1—7) metabolism in pulmonary and renal tissues
Allred, A. J., Diz, D. I., Ferrario, C. M., & Chappell, M. C. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.5.f841 · Cited by 124
Gomes, E. R. D. M., Lara, A., Almeida, P., Guimarães, D., Resende, R. R., Campagnole‐Santos, M. J., Bäder, M., Santos, R. A. S., & Guatimosim, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.143255 · Cited by 122
Self-citationPutko, B. N., Wang, Z., Lo, J., Anderson, T. J., Becher, H. H., Dyck, J. R. B., Kassiri, Z., Oudit, G. Y., & on behalf of the Alberta HEART Investigators (2014) · PLoS ONE · doi:10.1371/journal.pone.0099495 · Cited by 121
Self-citationInvolvement of chymase-mediated angiotensin II generation in blood pressure regulation
Li, M., Liu, K., Michalicek, J., Angus, J. A., Hunt, J. E., Dell’Italia, L. J., Feneley, M. P., Graham, R. M., & Husain, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20805 · Cited by 114
Murine Recombinant Angiotensin-Converting Enzyme 2
Ye, M., Wysocki, J. A., González‐Pacheco, F. R., Salem, M., Evora, K., Garcia-Halpin, L., Poglitsch, M., Schuster, M., & BATLLE, D. C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.198622 · Cited by 108
Leonhardt, J., Villela, D. C., Teichmann, A., Munter, L. M., Mayer, M., Mardahl, M., Kirsch, S., Namsolleck, P., Lucht, K., Benz, V., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08814 · Cited by 108
Self-citationFlores‐Muñoz, M., Work, L. M., Douglas, K. B., Denby, L., Dominiczak, A. F., Graham, D., & Nicklin, S. A. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.177485 · Cited by 107
Zhang, Z.-Z., Wang, W., Jin, H., Chen, X., Cheng, Y., Xu, Y., Song, B., Penninger, J. M., Oudit, G. Y., & Zhong, J. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10156 · Cited by 107
Self-citationPatel, V. B., Zhong, J., Dong, F., Basu, R., Morton, J. S., Parajuli, N., McMurtry, M. S., Davidge, S. T., Kassiri, Z., & Oudit, G. Y. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03388 · Cited by 106
Self-citationPatel, V. B., Bodiga, S., Dong, F., Das, S. K., Wang, Z., Wang, W., Basu, R., Zhong, J., Kassiri, Z., & Oudit, G. Y. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.191650 · Cited by 105
Self-citationAlamandine attenuates sepsis-associated cardiac dysfunction via inhibiting MAPKs signaling pathways
Li, P., Chen, X.-R., Xu, F., Liu, C., Li, C., Liu, H., Wang, H., Sun, W. Y., Sheng, Y., & Kong, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.010 · Cited by 103
Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison
Villela, D. C., Leonhardt, J., Patel, N., Joseph, J. P., Kirsch, S., Hallberg, A., Unger, T., Bäder, M., Santos, R. A. S., Sumners, C., et al. (2014) · Clinical Science · doi:10.1042/cs20130515 · Cited by 102
Self-citationAngiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease
Chow, B. S. M., & Allen, T. J. (2016) · Clinical Science · doi:10.1042/cs20160243 · Cited by 98
Role of the receptor Mas in macrophage-mediated inflammation in vivo
Hammer, A., Yang, G., Friedrich, J., Kovacs, A., Lee, D.-H., Grave, K., Haase, S., Alenina, N. V., Grosch, J., Winkler, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612668113 · Cited by 98
Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro
Ocaranza, M. P., Lavandero, S., Jalil, J., Moya, J., Pinto, M., Novoa, U., Apablaza, F., González, L., Hernández, C., Varas‐Godoy, M., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328335d291 · Cited by 96
Bruce, E., Shenoy, V., Rathinasabapathy, A., Espejo, A., Horowitz, A. M., Oswalt, A., Francis, J., Nair, A. R., Unger, T., Raizada, M. K., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13044 · Cited by 93
Self-citationYayama, K., Hiyoshi, H., Imazu, D., & Okamoto, H. (2006) · Hypertension · doi:10.1161/01.hyp.0000244108.30909.27 · Cited by 93
Steckelings, U. M., Paulis, L., Namsolleck, P., & Unger, T. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328350261b · Cited by 91
Self-citationAlamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes
de Jesus, I. C. G., Scalzo, S., Alves, F., Marques, K., Resende, C. R., Bäder, M., Santos, R. A. S., & Guatimosim, S. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00153.2017 · Cited by 90
Self-citationMcMurray, J. J. V. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr093 · Cited by 87
Verano‐Braga, T., Schwämmle, V., Sylvester, M., Passos-Silva, D. G., Peluso, A. A., Etelvino, G. M., Santos, R. A. S., & Roepstorff, P. (2012) · Journal of Proteome Research · doi:10.1021/pr3001755 · Cited by 87
Self-citationMcCollum, L. T., Gallagher, P. E., & Tallant, E. A. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00908.2011 · Cited by 86
Lauer, D., Slavić, S., Sommerfeld, M., Thöne‐Reineke, C., Sharkovska, Y., Hallberg, A., Dahlöf, B., Kintscher, U., Unger, T., Steckelings, U. M., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02522 · Cited by 83
Self-citationSatoh, M., Nakamura, M., Satoh, H., Saitoh, H., Segawa, I., & Hiramori, K. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00827-5 · Cited by 75
Iwata, M., Enciso, J. S., & Greenberg, B. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00036.2009 · Cited by 75
Anti-fibrotic Potential of AT2 Receptor Agonists
Wang, Y., Borgo, M. P. D., Lee, H. W., Baraldi, D., Hirmiz, B., Gaspari, T. A., Denton, K. M., Aguilar, M., Samuel, C. S., & Widdop, R. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00564 · Cited by 74
Giani, J. F., Muñoz, M. C., Mayer, M. A., Veiras, L. C., Arranz, C. T., Taira, C. A., Turyn, D., Toblli, J. E., & Dominici, F. P. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00803.2009 · Cited by 70
Lo, J., Patel, V. B., Wang, Z., Levasseur, J. L., Kaufman, S., Penninger, J. M., & Oudit, G. Y. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.067165 · Cited by 70
Self-citationCell-Specific Functions of ADAM17 Regulate the Progression of Thoracic Aortic Aneurysm
Shen, M., Hu, M., Fedak, P. W. M., Oudit, G. Y., & Kassiri, Z. (2018) · Circulation Research · doi:10.1161/circresaha.118.313181 · Cited by 70
Self-citationFunctional Reconstitution of the Angiotensin II Type 2 Receptor and GiActivation
Hansen, J. L., Servant, G., Baranski, T., Fujita, T., Iiri, T., & Sheikh, S. P. (2000) · Circulation Research · doi:10.1161/01.res.87.9.753 · Cited by 69
Qi, Y., Shenoy, V., Wong, F., Li, H., Afzal, A., Mocco, J., Sumners, C., Raizada, M. K., & Katovich, M. J. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2011.056994 · Cited by 67
Oudit, G. Y., & Penninger, J. M. (2011) · Current Heart Failure Reports · doi:10.1007/s11897-011-0063-7 · Cited by 67
Self-citationEnhanced Angiotensin II-Induced Cardiac and Aortic Remodeling in ACE2 Knockout Mice
Alghamri, M. S., Weir, N. M., Anstadt, M. P., Elased, K. M., Gurley, S. B., & Morris, M. (2012) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412460124 · Cited by 67
Garabelli, P. J., Modrall, J. G., Penninger, J. M., Ferrario, C. M., & Chappell, M. C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040246 · Cited by 66
Genetic deletion of the alamandine receptor MRGD leads to dilated cardiomyopathy in mice
Oliveira, A. C. D. S., Melo, M. B., Motta‐Santos, D., Peluso, A. A., Souza-Neto, F., da Silva, R., Almeida, J. F., Canta, G., dos Reis, A. M., Gonçalves, G. K. N., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00075.2018 · Cited by 65
Self-citationBoudina, S., Han, Y. H., Pei, S., Tidwell, T. J., Henrie, B., Tuinei, J., Olsen, C. D., Sena, S., & Abel, E. D. (2012) · Diabetes · doi:10.2337/db12-0063 · Cited by 64
Habiyakare, B., Alsaadon, H., Mathai, M. L., Hayes, A., & Zulli, A. (2014) · International Journal of Experimental Pathology · doi:10.1111/iep.12087 · Cited by 61
Renal angiotensin II AT2receptors promote natriuresis in streptozotocin-induced diabetic rats
Hakam, A. C., Siddiqui, A. H., & Hussain, T. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00092.2005 · Cited by 61
Yang, R., Smolders, I. J., Vanderheyden, P., Demaegdt, H., Eeckhaut, A. V., Vauquelin, G., Lukaszuk, A., Tourwé, D., Chai, S. Y., Albiston, A. L., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.161836 · Cited by 61
Ocaranza, M. P., Rivera, P., Novoa, U., Pinto, M., González, L., Chiong, M., Lavandero, S., & Jalil, J. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283440665 · Cited by 61
Flores‐Muñoz, M., Godinho, B. M. D. C., Almalik, A., & Nicklin, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045564 · Cited by 60
Favorable Vascular Actions of Angiotensin-(1–7) in Human Obesity
Schinzari, F., Tesauro, M., Veneziani, A., Mores, N., Di Daniele, N., & Cardillo, C. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10280 · Cited by 57
Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure
Parajuli, N., Patel, V. B., Wang, W., Basu, R., & Oudit, G. Y. (2014) · Clinical Science · doi:10.1042/cs20130787 · Cited by 56
Self-citationGao, J., Zucker, I. H., & Gao, L. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu044 · Cited by 53
Patel, S. N., Ali, Q., Samuel, P., Steckelings, U. M., & Hussain, T. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09679 · Cited by 53
Self-citationHayashi, T., Takai, S., & Yamashita, C. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110790886947 · Cited by 51
Chamoux, E., Breault, L., Lehoux, J., & Gallo‐Payet, N. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6223 · Cited by 49
Dong, F., Takawale, A. R., Shen, M., Wang, W., Wang, X., Basu, R., Oudit, G. Y., & Kassiri, Z. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.002029 · Cited by 49
Self-citationRecombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure
Patel, V. B., Lezutekong, J. N., Chen, X., & Oudit, G. Y. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.12.012 · Cited by 49
Self-citationHuman angiotensin receptor subtypes
Smith, R. D., Pieter, & Timmermans (1994) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199401000-00016 · Cited by 47
Antagonism of angiotensin 1–7 prevents the therapeutic effects of recombinant human ACE2
Patel, V. B., Takawale, A. R., Ramprasath, T., Das, S. K., Basu, R., Grant, M. B., Hall, D. A., Kassiri, Z., & Oudit, G. Y. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1285-z · Cited by 46
Self-citationThe angiotensin AT2 receptor in inflammation
Rompe, F., Unger, T., & Steckelings, U. M. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.2.1475901 · Cited by 45
Self-citationPeluso, A. A., Bertelsen, J. B., Andersen, K., Mortensen, T. P., Hansen, P., Sumners, C., Bäder, M., Santos, R. A. S., & Steckelings, U. M. (2018) · Clinical Science · doi:10.1042/cs20171598 · Cited by 45
Self-citationDong, F., Takawale, A. R., Shen, M., Samokhvalov, V., Basu, R., Patel, V. B., Wang, X., Fernández-Patrón, C., Seubert, J. M., Oudit, G. Y., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07566 · Cited by 44
Self-citationAlamandine reverses hyperhomocysteinemia‐induced vascular dysfunction via PKA ‐dependent mechanisms
Qaradakhi, T., Matsoukas, M., Hayes, A., Rybalka, E., Čaprnda, M., Rimárová, K., Sepši, M., Büsselberg, D., Kružliak, P., Matsoukas, J., et al. (2017) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12306 · Cited by 42
New therapeutic pathways in the RAS
Bäder, M., Santos, R. A. S., Unger, T., & Steckelings, U. M. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312466519 · Cited by 41
Self-citationSatoh, M., Iwasaka, J., Nakamura, M., Akatsu, T., Shimoda, Y., & Hiramori, K. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.02.007 · Cited by 40
Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease
Wang, W., Patel, V. B., Parajuli, N., Dong, F., Basu, R., Wang, Z., Ramprasath, T., Kassiri, Z., Penninger, J. M., & Oudit, G. Y. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1149-y · Cited by 40
Self-citationShen, M., Morton, J. S., Davidge, S. T., & Kassiri, Z. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.12.001 · Cited by 38
Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor
Steckelings, U. M., de Kloet, A. D., & Sumners, C. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.06.002 · Cited by 37
Self-citationAlamandine reduces leptin expression through the c-Src/p38 MAP kinase pathway in adipose tissue
Uchiyama, T., Okajima, F., Mogi, C., Tobo, A., Tomono, S., & Sato, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178769 · Cited by 36
Cardiovascular effects of angiotensin A: A novel peptide of the renin–angiotensin system
Coutinho, D. C. O., Foureaux, G., Rodrigues, K. D., Salles, R. L., Moraes, P. L., Murça, T. M., Maria, M. L. A. D., Gomes, E. R. D. M., Santos, R. A. S., Guatimosim, S., et al. (2013) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312474856 · Cited by 34
Self-citationSoares, E. R., Barbosa, C. M., Campagnole‐Santos, M. J., Santos, R. A. S., & Alzamora, A. C. (2017) · Peptides · doi:10.1016/j.peptides.2017.09.005 · Cited by 34
Self-citationEccentric Overload Muscle Damage is Attenuated By a Novel Angiotensin- (1-7) Treatment
Becker, L. K., Totou, N. L., de Moura, S. S., Kangussu, L. M., Millán, R. D. S., Campagnole‐Santos, M. J., Coelho, D. B., Motta‐Santos, D., & Santos, R. A. (2018) · International Journal of Sports Medicine · doi:10.1055/a-0633-8892 · Cited by 33
Self-citationHekmat, A. S., Javanmardi, K., Kouhpayeh, S. A., Baharamali, E., & Farjam, M. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-0958 · Cited by 29
Alteration of Cardiac ACE2/Mas Expression and Cardiac Remodelling in Rats with Aortic Constriction
Zhang, Y. (2014) · The Chinese Journal of Physiology · doi:10.4077/cjp.2014.bad268 · Cited by 28
Shen, Y., Chen, X.-R., Yang, C.-X., Liu, B.-X., & Li, P. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.014 · Cited by 27
Nakao, Y. M., Teramukai, S., Tanaka, S., Yasuno, S., Fujimoto, A., Kasahara, M., Ueshima, K., Nakao, K., Hinotsu, S., Nakao, K., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.11.025 · Cited by 24
Chamoux, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4722 · Cited by 22
AT2 receptors recruit c-Src, SHP-1 and FAK upon activation by Ang II in PND15 rat hindbrain
Seguin, L. R., Villarreal, R., & Ciuffo, G. M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.11.008 · Cited by 11
Cited by
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
Self-citationCOVID-19, ACE2, and the cardiovascular consequences
South, A. M., Diz, D. I., & Chappell, M. C. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00217.2020 · Cited by 762
Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 339
Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
Bekassy, Z., Lopatko Fagerström, I., Bader, M., & Karpman, D. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-021-00634-8 · Cited by 167
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings, U. M., Widdop, R. E., Sturrock, E. D., Lubbe, L., Hussain, T., Kaschina, E., Unger, T., Hallberg, A., Carey, R. M., & Sumners, C. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000281 · Cited by 97
Self-citation
Metadata
- Authors
- Santos, R. A. S., Oudit, G. Y., Verano-Braga, T., Canta, G., Steckelings, U. M., & Bader, M.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2019-05-01
- Volume
- 316
- Issue
- 5
- Pages
- H958-H970
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2914853620
- Cited by
- 340
- References
- 165
- FWCI
- 27.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.